首页 | 本学科首页   官方微博 | 高级检索  
检索        

高血压病人纤维蛋白原水平及纤溶系统功能研究
引用本文:陈红.高血压病人纤维蛋白原水平及纤溶系统功能研究[J].心肺血管病杂志,1999,0(1):16-17.
作者姓名:陈红
作者单位:北京医科大学人民医院,100044,心内科
摘    要:为了解高血压病人的血栓形成倾向,我们随机选取了41例高血压病人及34例正常血压者,分别观察了他们的纤维蛋白原及血浆组织型纤溶酶原激活物(tPA)抗原及纤溶酶原激活物抑制物-1(PAI-1)的含量。结果表明,高血压病人血浆纤维蛋白原水平无明显变化,但tPA抗原含量减少,PAI-1的水平增加。提示高血压病人存在内源性纤溶功能受损

关 键 词:高血压病  纤维蛋白原  组织型纤溶酶原激活物  纤溶酶原激活物抑制剂

Plasma Level of Fibrinogen and Fibrinolysis in Essential Hypertension Patients
Chen Hong.Plasma Level of Fibrinogen and Fibrinolysis in Essential Hypertension Patients[J].Journal of Cardiovascular and Pulmonary Diseases,1999,0(1):16-17.
Authors:Chen Hong
Abstract:In order to study the ability to the thrombus formation,41 patients with essential hypertension and 34 patients with normotension were investigated.The plasma level of fibrinogen and tissue-type plasminogen activator(tPA) antigen and plasminogen activator inhibitor 1(PAI-1)antigen were determined.In comparing with normotensive subjects,essential hypertensive patients had higher plasma concentration of PAI-1 antigen(P>0.05)and lower plasma level of tPA antigen (P<0.05),but similar plasma level of fibrinogen(P>0.05).The results suggest that there is impaired fibrinolysis in patients with hypertension.
Keywords:Essential hypertension  \ Fibrinogen  \ Tissue-type plasminogen activator  \ Plasminogen activator inhibitor 1  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号